Sclerostin and Wnt Signaling in Idiopathic Juvenile Osteoporosis Using High-Resolution Confocal Microscopy for Three-Dimensional Analyses
Open Access
Abstract
Background: Idiopathic juvenile osteoporosis (IJO) is a rare condition characterized by low bone mass that can increase the risk of fractures in children. Treatment options for these patients are limited as the molecular mechanisms of disease initiation and progression are incompletely understood. Sclerostin inhibits canonical Wnt signaling, which is important for the bone formation activity of osteoblasts, and elevated sclerostin has been implicated in adult osteoporosis. Objective: To evaluate the role of sclerostin in IJO, high-resolution confocal microscopy analyses were performed on bone biopsies collected from 13 pediatric patients. Methods: Bone biopsies were stained with sclerostin, and β-catenin antibodies showed elevated expression across osteocytes and increased sclerostin-positive osteocytes in 8 of the 13 total IJO patients (62%). Results: Skeletal sclerostin was associated with static and dynamic histomorphometric parameters. Further, colocalization analyses showed that bone sclerostin colocalized with phosphorylated β-catenin, a hallmark of Wnt signaling that indicates Wnt inhibition. In contrast, sclerostin-positive osteocytes were not colocalized with an “active” unphosphorylated form of β-catenin. Conclusions: These results support a model that altered levels of sclerostin and Wnt signaling activity occur in IJO patients.Keywords
Funding Information
- USPHS (DK-35423, DK-67563, U01DK122013, NCATS UL1 TR000122)
- Connie Frank Bone Laboratory (DK-35423, DK-67563, U01DK122013, NCATS UL1 TR000122)
- AP Giannini (DK-35423, DK-67563, U01DK122013, NCATS UL1 TR000122)
- Cystinosis Research Foundation (CRF) (DK-35423, DK-67563, U01DK122013, NCATS UL1 TR000122)
This publication has 42 references indexed in Scilit:
- One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational StudyCalcified Tissue International, 2022
- Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated PatientsCalcified Tissue International, 2018
- The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar SpineJournal of Bone and Mineral Research, 2014
- Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophyJournal of Bone and Mineral Research, 2012
- The amazing osteocyteJournal of Bone and Mineral Research, 2010
- Relation of age, gender, and bone mass to circulating sclerostin levels in women and menJournal of Bone and Mineral Research, 2010
- Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient casesJournal of Cancer Research and Clinical Oncology, 2010
- Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complicationsOsteoporosis International, 2007
- A 52‐kb deletion in the SOST‐MEOX1 intergenic region on 17q12‐q21 is associated with van Buchem disease in the Dutch populationAmerican Journal of Medical Genetics, 2002
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987